Medicare Beneficiary Receipt of Methadone by Drive Time to Opioid Treatment Programs

View Resource

Examines availability of methadone at opioid treatment programs for Medicare beneficiaries who have been diagnosed with an opioid use disorder. Utilizes data from 640,706 Medicare beneficiaries and analyzes their respective drive time to a treatment facility as well as receipt of methadone treatment. Includes U.S. map showing locations of opioid treatment programs and rural versus urban comparisons of patient drive times.

Jonathan Cantor, Helin G. Hernandez, Aaron Kofner, et al.

JAMA Network Open, 8(4)

04/2025

Access · Illicit drug use · Medicare · Rural-urban differences · Specialty care